ABM Therapeutics begins phase 1 trial of BRAF inhibitor ABM-1310

pharmanewsdaily- June 23, 2020 0

ABM Therapeutics said that the first cancer patient has been enrolled and dosed with its lead candidate ABM-1310, a BRAF inhibitor, in a phase 1 ... Read More

Differences between Malignant Tumors and Benign Tumors

pharmanewsdaily- November 24, 2013 0

What are the Characteristics of Neoplasia? Neoplasia comprises of both malignant and benign tumors. What are the differences between Malignant Tumors and Benign Tumors? Benign ... Read More